High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients. (2nd May 2018)

• Record Type: Journal Article
• Authors: Schuster, Anne J.; Kager, Leo; Reichardt, Peter; Baumhoer, Daniel; Csóka, Monika; Hecker-Nolting, Stefanie; Lang, Susanna; Lorenzen, Sylvie; Mayer-Steinacker, Regine; von Kalle, Thekla; Kevric, Matthias; Werner, Mathias; Windhager, Reinhard; Wirth, Thomas; Bielack, Stefan S.
• Other Names: Lewis Valerae O. Academic Editor.
• Is Part Of: Sarcoma. Volume 2018(2018)
• Publication Date: 2018-05-02
• Subjects: Sarcoma -- Periodicals; 616.994
• DOI: 10.1155/2018/1632978
• Languages: English
• ISSNs: 1357-714X

Abstract

Abstract : Osteosarcoma of the foot is a very rare presentation of a rare tumor entity. In a retrospective analysis, we investigated tumor- and treatment-related variables and outcome of patients registered in the Cooperative Osteosarcoma Study Group (COSS) database between January 1980 and April 2016 who suffered from primary high-grade osteosarcoma of the foot. Among the 23 eligible patients, median age was 32 years (range: 6–58 years), 10 were female, and 13 were male. The tarsus was the most commonly affected site (n = 16 ). Three patients had primary metastases. All patients were operated: 5 underwent primary surgery and 18 received surgery following preoperative chemotherapy. In 21 of the 23 patients, complete surgical remission was achieved. In 4 of 17 patients, a poor response to neoadjuvant chemotherapy was observed in the resected primary tumors. Median follow-up was 4.2 years (range: 0.4–18.5). At the last follow-up, 15 of the 23 patients were alive and 8 had died. Five-year overall and event-free survival estimates were 64% (standard error (SE) 12%) and 54% (SE 13%), which is similar to that observed for osteosarcoma in general. Event-free and overall survival correlated with primary metastatic status and completeness of surgery. Our findings show that high-grade osteosarcoma in the foot has a similar outcome as osteosarcoma of other sites.